Identifiers
Database identifiers and provenance.
- Ligand ID
00J- PDB
2xir- UniProt (similar protein)
P35968- Target protein
- P10721
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 86.1
- −1 ≤ LogP ≤ 5 4.15
- MW ≤ 500 Da 461.5
- LogP ≤ 5 4.15
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 86.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(c2ccc(cc2o1)Oc3ccnc4c3ccc(c4)OCCN5CCOCC5)C(=O)NCCc1c(c2ccc(cc2o1)Oc3ccnc4c3ccc(c4)OCCN5CCOCC5)C(=O)NC
InChI=1S/C26H27N3O5/c1-17-25(26(30)27-2)21-6-4-19(16-24(21)33-17)34-23-7-8-28-22-15-18(3-5-20(22)23)32-14-11-29-9-12-31-13-10-29/h3-8,15-16H,9-14H2,1-2H3,(H,27,30)InChI=1S/C26H27N3O5/c1-17-25(26(30)27-2)21-6-4-19(16-24(21)33-17)34-23-7-8-28-22-15-18(3-5-20(22)23)32-14-11-29-9-12-31-13-10-29/h3-8,15-16H,9-14H2,1-2H3,(H,27,30)
LGXVKMDGSIWEHL-UHFFFAOYSA-NLGXVKMDGSIWEHL-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- PDB
- Binding sites
- PF07714
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 00J →
- PDB RCSB structure 2xir →
- UniProt UniProt P35968 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “00J”) →
Other ligands for this protein
Quick navigation to other ligands bound to P10721.
PDB 232
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).